OBJECTIVES: Policy efforts to reduce the cost of prescription medications in the US have failed to reduce disparities in cost-related underuse. Little is known about the relationships between pharmacy accessibility, utilization, and cost-related underuse of prescription medications among residents of low-income minority communities. The aim of this work was to examine the association between pharmacy accessibility, utilization, and cost-related underuse of prescription medications among residents of predominantly low-income Black and Hispanic urban communities. METHODS: Data from a population-based probability sample of adults 35 years of age and older residing on the South Side of Chicago in 2012-2013 were linked with the use of geocoded information on the type and location of the primary and the nearest pharmacy. Multivariable regression models were used to examine associations between pharmacy accessibility, utilization of and travel distance to the primary pharmacy, and cost-related underuse overall and by pharmacy type. RESULTS: One-third of South Side residents primarily filled their prescriptions at the pharmacy nearest to their home. Among those who did not use mail order, median distance traveled from home to the primary pharmacy was 1.2 miles. Residents whose primary pharmacy was at a community health center or clinic where they usually received care traveled the farthest but were least likely to report cost-related underuse of their prescription medications. CONCLUSION: Most residents of minority communities on Chicago's South Side were not using the pharmacies closest to their home to obtain their prescription medications. Efforts to improve access to prescription medications in these communities should focus on improving the accessibility of affordable pharmacies at site of care.
OBJECTIVES: Policy efforts to reduce the cost of prescription medications in the US have failed to reduce disparities in cost-related underuse. Little is known about the relationships between pharmacy accessibility, utilization, and cost-related underuse of prescription medications among residents of low-income minority communities. The aim of this work was to examine the association between pharmacy accessibility, utilization, and cost-related underuse of prescription medications among residents of predominantly low-income Black and Hispanic urban communities. METHODS: Data from a population-based probability sample of adults 35 years of age and older residing on the South Side of Chicago in 2012-2013 were linked with the use of geocoded information on the type and location of the primary and the nearest pharmacy. Multivariable regression models were used to examine associations between pharmacy accessibility, utilization of and travel distance to the primary pharmacy, and cost-related underuse overall and by pharmacy type. RESULTS: One-third of South Side residents primarily filled their prescriptions at the pharmacy nearest to their home. Among those who did not use mail order, median distance traveled from home to the primary pharmacy was 1.2 miles. Residents whose primary pharmacy was at a community health center or clinic where they usually received care traveled the farthest but were least likely to report cost-related underuse of their prescription medications. CONCLUSION: Most residents of minority communities on Chicago's South Side were not using the pharmacies closest to their home to obtain their prescription medications. Efforts to improve access to prescription medications in these communities should focus on improving the accessibility of affordable pharmacies at site of care.
Authors: Stacy Tessler Lindau; Ramona James; Jennifer A Makelarski; Ernest Sanders; Daniel Johnson Journal: Am J Public Health Date: 2012-05-17 Impact factor: 9.308
Authors: Benjamin D Sommers; Thomas Musco; Kenneth Finegold; Munira Z Gunja; Amy Burke; Audrey M McDowell Journal: N Engl J Med Date: 2014-07-23 Impact factor: 91.245
Authors: Dima M Qato; Stacy Tessler Lindau; Rena M Conti; L Philip Schumm; G Caleb Alexander Journal: Pharmacoepidemiol Drug Saf Date: 2010-08 Impact factor: 2.890
Authors: Stacy T Lindau; Jennifer Makelarski; Emily Abramsohn; David G Beiser; Veronica Escamilla; Jessica Jerome; Daniel Johnson; Abel N Kho; Karen K Lee; Timothy Long; Doriane C Miller Journal: Health Aff (Millwood) Date: 2016-11-01 Impact factor: 6.301
Authors: Walid F Gellad; Niteesh K Choudhry; Mark W Friedberg; M Alan Brookhart; Jennifer S Haas; William H Shrank Journal: Health Serv Res Date: 2008-11-04 Impact factor: 3.402
Authors: Chien-Wen Tseng; Edward F Tierney; Robert B Gerzoff; R Adams Dudley; Beth Waitzfelder; Ronald T Ackermann; Andrew J Karter; John Piette; Jesse C Crosson; Quyen Ngo-Metzger; Richard Chung; Carol M Mangione Journal: Diabetes Care Date: 2007-11-13 Impact factor: 19.112
Authors: Wesley Yin; Anirban Basu; James X Zhang; Atonu Rabbani; David O Meltzer; G Caleb Alexander Journal: Ann Intern Med Date: 2008-01-07 Impact factor: 25.391
Authors: Avani C Modi; Anup D Patel; Jack Stevens; Gigi Smith; Heather Huszti; Shanna M Guilfoyle; Constance A Mara; Matthew Schmidt; Janelle L Wagner Journal: Epilepsy Behav Date: 2021-02-12 Impact factor: 2.937
Authors: Peter K Yang; Matthew D Ritchey; Stavros Tsipas; Fleetwood Loustalot; Gregory D Wozniak Journal: Prev Chronic Dis Date: 2020-09-24 Impact factor: 2.830
Authors: Mark A Strand; Natalie A DiPietro Mager; Lori Hall; Sarah Levin Martin; Daniel F Sarpong Journal: Prev Chronic Dis Date: 2020-09-24 Impact factor: 2.830